Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The 2022 OncoAlert Colloquium Day 6: EONS Sessions

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 6: EONS Sessions ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 5: GI Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 3: Lung Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 2: GU Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

HER-Vaxx is safe and provides clinical benefit over standard of care chemo for...

Dr Tanuj Chawla and Dr Giovanni Selvaggi

HER-Vaxx is safe and provides clinical benefit over standard of care chemo for patients with HER2-overexpressing gastric cancer ( Dr Tanuj Chawla and Dr Giovanni Selvaggi )

Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows...

Dr Emma Searle - University of Manchester, Manchester, UK

Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma ( Dr Emma Searle - University of Manchester, Manchester, UK )

Redefining cancer research priorities in the emerging context of the COVID-19...

Prof Richard Sullivan - King's College London, London, UK

Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )

Cervical cancer prevention and care indicators for women living with HIV in Sub...

Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil...

Cervical cancer prevention and care indicators for women living with HIV in Sub-Saharan Africa: Delphi Method ( Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil, Switzerland )

Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival...

Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA

Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival benefit in R/R multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )

Prognostic model of all-cause mortality at 30 days in patients with cancer and...

Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19 ( Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer